GGrantIndex
Sort

40,608 grants matching prostate cancer

Molecular Epidemiology of Fatal Prostate Cancer

$491,009
Kaiser Foundation Research Institute · R01 · FY2005 · CA

Prospective Studies of Diet and Cancer in Men and Wonen

$490,980
Walter C. Willett · Harvard School Of Public Health · P01 · FY2006 · CA

OSTEOPOROTIC FRACTURES IN MEN

$490,972
University Of Pittsburgh At Pittsburgh · U01 · FY2005 · AR

THERAPEUTIC MANUFACTURING

$490,937
Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2013 · CA

Implementation of evidence-based cancer early detection in Black churches

$490,931
Cheryl L Holt · Univ Of Maryland, College Park · R01 · FY2011 · CA

A Brief Patient-Controlled Intervention for a Symptom Cluster in Advanced Cancer

$490,856
Kristine L Kwekkeboom · University Of Wisconsin-Madison · R01 · FY2015 · NR

Characterization of Cancer Stem Cells

$490,842
William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

A Combination Therapy to Treat Cancer-Related Fatigue

$490,675
Sriram Yennu · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer

$490,625
Mathew L Thakur · Thomas Jefferson University · R01 · FY2016 · CA

RESEARCH CAPACITY CORE

$490,594
Geou-Yarh Liou · Clark Atlanta University · U54 · FY2025 · MD

Outreach Core

$490,592
Tim Alan Ahles · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA

Exploiting RB1 deficiency for the treatment of lethal neuroendocrine prostate cancer

$490,587
David W Goodrich · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA

Optimizing Age-based Anal Cancer Screening Among People Living with HIV using Decision Analytic Modeling

$490,571
Ashish A. Deshmukh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · CA

Hexokinase 2 and cancer therapy

$490,487
Nissim Hay · University Of Illinois At Chicago · R01 · FY2021 · CA

Tissue/Informatics Core

$490,416
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2012 · CA

Targeting the PI3K Signaling Axis

$490,407
Thomas M Roberts · Massachusetts General Hospital · P50 · FY2014 · CA

The role of exercise in vaccine-mediated immunity

$490,390
John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

MDA-7/IL-24: Therapy of Prostate Cancer

$490,383
Paul B Fisher · Virginia Commonwealth University · P01 · FY2009 · CA

Developing Diagnostic and Therapeutic Strategies to Reduce Hispanic Cancer Disparities Using Genetic, Molecular and Physiological Signatures from Mexican origin Cancer Patients

$490,360
Jianying Zhang · University Of Texas El Paso · U54 · FY2021 · MD

Phase II Chemoprevention Trial of Selenium and Prostate Cancer

$490,328
University Of Arizona · R01 · FY2005 · CA

Mcl-1 in apoptosis and signal transduction: a structure/function approach

$490,308
Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA

Prostate Cancer Education in African American Men

$490,254
Stephen J Lepore · Temple Univ Of The Commonwealth · R01 · FY2007 · CA

Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival

$490,230
Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA

Microendoscopic Electrical Impedance Sensing for Real-time Intraoperative Surgical Margin Assessment

$490,176
Ryan Joseph Halter · Dartmouth College · R01 · FY2022 · CA

FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A

$490,082
Jindan Yu · Emory University · R01 · FY2024 · CA